[go: up one dir, main page]

CL2011002535A1 - Método para producir microesferas que comprenden un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; y las microesferas producidas. - Google Patents

Método para producir microesferas que comprenden un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; y las microesferas producidas.

Info

Publication number
CL2011002535A1
CL2011002535A1 CL2011002535A CL2011002535A CL2011002535A1 CL 2011002535 A1 CL2011002535 A1 CL 2011002535A1 CL 2011002535 A CL2011002535 A CL 2011002535A CL 2011002535 A CL2011002535 A CL 2011002535A CL 2011002535 A1 CL2011002535 A1 CL 2011002535A1
Authority
CL
Chile
Prior art keywords
microspheres
whey protein
active component
matrix
component encapsulated
Prior art date
Application number
CL2011002535A
Other languages
English (en)
Inventor
Andre Doherty Sinead Brodkorb
Original Assignee
Agricultore And Food Dev Authority Teagasc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42321200&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011002535(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Agricultore And Food Dev Authority Teagasc filed Critical Agricultore And Food Dev Authority Teagasc
Publication of CL2011002535A1 publication Critical patent/CL2011002535A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/30—Removing undesirable substances, e.g. bitter substances
    • A23L11/34—Removing undesirable substances, e.g. bitter substances using chemical treatment, adsorption or absorption
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0052—Preparation of gels
    • B01J13/0065—Preparation of gels containing an organic phase
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

Método de producción de microesferas que comprende un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; dichas microesferas; formulación que las comprende; un producto lácteo; método de liberación de un agente activo en el tramo inferior del intestino y protección del agente activo durante el paso por el estómago.
CL2011002535A 2009-04-13 2011-10-12 Método para producir microesferas que comprenden un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; y las microesferas producidas. CL2011002535A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16874609P 2009-04-13 2009-04-13

Publications (1)

Publication Number Publication Date
CL2011002535A1 true CL2011002535A1 (es) 2013-02-01

Family

ID=42321200

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011002535A CL2011002535A1 (es) 2009-04-13 2011-10-12 Método para producir microesferas que comprenden un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; y las microesferas producidas.

Country Status (6)

Country Link
US (2) US9089152B2 (es)
EP (1) EP2418968B1 (es)
CA (1) CA2758620C (es)
CL (1) CL2011002535A1 (es)
ES (1) ES2564190T3 (es)
WO (1) WO2010119041A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9788563B2 (en) * 2011-04-15 2017-10-17 Pepsico, Inc. Encapsulation system for protection of probiotics during processing
US9320297B2 (en) * 2012-03-22 2016-04-26 Lemniscate Innovations Llc Spherification/reverse spherification automated and integrated system and method
RU2666989C2 (ru) * 2012-06-07 2018-09-13 Сомалоджик, Инк. Мультиплексные анализы на основе аптамеров
US20150299516A1 (en) * 2012-11-26 2015-10-22 Progel Pty Ltd Coating composition
US10188609B2 (en) 2012-11-29 2019-01-29 Progel Pty Ltd Microparticles comprising a probiotic, cross-linkable reagent, a denatured protein, polyol plasticiser and trehalose
US10449157B2 (en) 2013-06-12 2019-10-22 Anabio Technologies Limited Process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell
GB201312245D0 (en) * 2013-07-08 2013-08-21 Gorman Eddie O An extrusion process
JP6758285B2 (ja) * 2014-11-19 2020-09-23 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 乳清タンパク質ミセルとペクチンの複合体及び身体筋肉タンパク質合成
RU2646788C2 (ru) * 2014-11-27 2018-03-07 Общество с ограниченной ответственностью "Изварино Фарма" Применение соли альгината в качестве сорбента липидов, фармацевтическая композиция и лекарственный препарат для лечения ожирения
CA2970977C (en) * 2014-12-15 2022-10-25 Anabio Technologies Limited Gastro-resistant microencapsulates, and uses thereof to stimulate in-vivo ileal glp-1 release in a mammal
GB201508745D0 (en) 2015-05-21 2015-07-01 Anabio Technologies Ltd A method of producing microparticles of the type having a crosslinked, aggregated protein matrix by spray drying
FR3048884B1 (fr) * 2016-03-18 2021-07-30 Capsulae Composition pour l'administration par voie orale d'au moins un principe actif a un sujet
US20200317738A1 (en) 2016-05-26 2020-10-08 University College Cork - National University Of Ireland, Cork Methods for increasing proliferation of mammalian cells
WO2017203051A1 (en) 2016-05-26 2017-11-30 University College Cork - National University Of Ireland, Cork An engineered gram positive bacterium
CA3073615A1 (en) 2017-08-25 2019-02-28 University College Cork - National University Of Ireland Cork Bifidobacterium longum for treating obesity and weight management
CA3083711A1 (en) 2017-11-24 2019-05-31 University College Cork, National University Of Ireland, Cork A composition comprising a cohort of bacteria
WO2019170840A1 (en) 2018-03-07 2019-09-12 Anabio Technologies Ltd. A composition for type ii diabetics and for use in providing sustained energy release over time
NL2025932B1 (en) 2020-06-26 2022-02-21 Iamfluidics Holding B V Micro-fluidic system and method
EP3939596A1 (en) 2020-07-14 2022-01-19 Bimeda Animal Health Limited A composition for treating helminth infestation in a mammal
GB202011598D0 (en) 2020-07-27 2020-09-09 Anabio Tech Limited A pharmaceutical composition in oral dosage form
CN111838675A (zh) * 2020-08-25 2020-10-30 无限极（中国）有限公司 一种制备油脂微球粉体的方法
EP4046643A1 (en) 2021-02-23 2022-08-24 University College Cork - National University of Ireland, Cork A method of treating or preventing colorectal cancer
CN112956697B (zh) * 2021-03-12 2023-03-28 浙江工商大学 鼠李糖乳杆菌微胶囊的制备方法
EP4070670A1 (en) 2021-04-08 2022-10-12 University College Cork-National University of Ireland Cork Lacticaseibacillus paracasei em025-11 and uses thereof
IT202300018129A1 (it) 2023-09-04 2025-03-04 Univ Degli Studi Di Bari Aldo Moro Microcapsule contenenti ceppi probiotici e procedimento per la loro preparazione.
GB202403584D0 (en) 2024-03-12 2024-04-24 Anabio Tech Limited An enumeration method
WO2025212191A1 (en) * 2024-04-01 2025-10-09 Vitakey Inc. Heat-treated extended-release formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217370A (en) * 1977-08-25 1980-08-12 Blue Wing Corporation Lipid-containing feed supplements and foodstuffs
US5750183A (en) * 1993-11-16 1998-05-12 Takeda Food Products, Ltd. Process for producing proteinaceous microparticles
AU3601497A (en) 1996-06-18 1998-01-07 Bush Boake Allen Inc. Method of encapsulation and product produced thereby
EP1234507A1 (en) * 2001-02-26 2002-08-28 Wageningen Centre for Food Sciences Process for isolating beta-lactoglobulin from milk or milk fractions
EP1371410A1 (en) * 2002-06-14 2003-12-17 NIZO food research Complex coacervates containing whey proteins
IL160095A0 (en) 2004-01-28 2004-06-20 Yissum Res Dev Co Formulations for poorly soluble drugs
US20080044481A1 (en) * 2004-05-27 2008-02-21 Mordechai Harel Microparticles for Oral Delivery
WO2007034213A1 (en) * 2005-09-24 2007-03-29 Cambridge Applied Polymers Limited Process for encapsulation of edible oil products with whey protein and encapsulated edible oil products

Also Published As

Publication number Publication date
EP2418968A2 (en) 2012-02-22
US20120156252A1 (en) 2012-06-21
CA2758620C (en) 2018-10-16
WO2010119041A3 (en) 2011-01-13
US10271569B2 (en) 2019-04-30
US20150320097A1 (en) 2015-11-12
EP2418968B1 (en) 2015-12-02
US9089152B2 (en) 2015-07-28
CA2758620A1 (en) 2010-10-21
ES2564190T3 (es) 2016-03-18
WO2010119041A2 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
CL2011002535A1 (es) Método para producir microesferas que comprenden un componente activo encapsulado al interior de una matriz de proteína de suero gelificada; y las microesferas producidas.
CL2013000347A1 (es) Poblacion de microparticulas que comprenden un corticoesteroide clase b incorporado en una matriz formada por un copolimero de acido lactico y acido glicolico, donde dicho corticoesteroide comprende entre 22% a 28% de las microparticulas; preparacion de liberacion controlada; formulacion; y metodo de fabricacion.
WO2017091749A8 (en) Shape changing drug delivery devices and methods
MX2019003467A (es) Formulaciones y metodos para la administracion vaginal de antiprogestinas.
AR077676A1 (es) Alimento para animales y su apariencia
BR112012023324B8 (pt) processo de preparação de uma forma de dosagem multifásica liofilizada de dissolução rápida
MX2012003204A (es) Forma de dosificacion solida oral que contiene nanoparticulas y proceso para su formulacion utilizando gelatina de pescado.
WO2014165308A3 (en) Microsphere drug delivery system for sustained intraocular release
CL2014000759A1 (es) Composicion para uso en el crecimiento del cerebro y/o desarrollo cognitivo y/o desarrollo psicomotor que comprende al menos un ácido graso poliinsaturado de cadena larga (lc-pufa), al menos un probiótico y una mezcla de oligosacáridos; uso de la composición.
AR082384A1 (es) Particulas
EP3861982A3 (en) Intracameral implant for treatment of an ocular condition
MX382443B (es) Una formulación estable para usarse en el tratamiento de la enfermedad por leucodistrofia metacromática (mld).
EP2872118A4 (en) HYDROGEL FUEL CAPSULE, FORMULATIONS AND METHOD FOR THE MANUFACTURE THEREOF
BR112014031914A2 (pt) cápsula de estradiol solúvel para inserção vaginal
PE20140255A1 (es) Tableta dispersable en forma oral
BR112015022161A2 (pt) implante intraocular contendo prostamida
MY191875A (en) Solid dosage form
BR112013007740A2 (pt) métodos para processamento de microesferas, microesferas processadas por tais métodos e seus usos
AR083328A1 (es) Particula de suministro
BR112012027794A2 (pt) tablete entérico
AR086395A1 (es) Envase para el tratamiento de patologias
CL2013002700A1 (es) Cápsula suave ingerible que contiene inositol y excipientes, o inositol, excipientes y al menos un principio activo adicional, tal como ácido fólico, polifenoles de cocoa, genisteína, l-arginina, vitamina e, selenio, n-acetilcisteína y melatonina; útil para el tratamiento del ovario poliquístico, resistencia a la insulina y otros
MX369742B (es) Formulación de liberación modificada.
MX2016014256A (es) Formulaciones y metodos para el suministro vaginal de antiprogestinas.
BR112012027782A2 (pt) tablete entérico